FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3849911000001107: Renagel 403mg capsules (Genzyme Therapeutics) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17901101000001116 Renagel 403mg capsules (Genzyme Therapeutics) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41401701000001117 Renagel 403mg capsules (Genzyme Therapeutics Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Renagel 403mg capsules (Genzyme Therapeutics) Is a Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has active ingredient Sevelamer false Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Is a Renagel true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has specific active ingredient Sevelamer false Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) Has specific active ingredient Sevelamer true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Renagel 403mg capsules (Genzyme Therapeutics) 200 capsule Is pack of False Renagel 403mg capsules (Genzyme Therapeutics) Inferred relationship Existential restriction modifier
Renagel 403mg capsules (Genzyme Therapeutics) 200 capsule Has AMP True Renagel 403mg capsules (Genzyme Therapeutics) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start